CDXC Chart
- 52-Week Range: $1.59 - $10.54
- Market Capitalization: $123.69M
- Short Percentage: 0%
- Target Price: $8.39
- Shares Outstanding: 68.33M
- Next Earnings: Nov 30
Catalysts
CategoryCatalyst
Earnings
CDXC released their earnings report for the previous quarter and provided guidance on the current and upcoming quarters.
News and Press Releases
- ChromaDex Announces Agreement to Launch Commercial Joint Venture in Mainland ChinaBusiness Wire | May 19th
- ChromaDex Corporation (CDXC) CEO Rob Fried on Q1 2022 Results - Earnings Call TranscriptSeeking Alpha | May 12th
- ChromaDex to Report First Quarter 2022 Financial Results on Thursday, May 12, 2022Business Wire | April 29th
- ChromaDex Launches Tru Niagen® Immune, Further Expanding Innovative Product PortfolioBusiness Wire | April 6th
- ChromaDex Corporation (CDXC) CEO Rob Fried on Q4 2021 Results - Earnings Call TranscriptSeeking Alpha | March 9th
- ChromaDex Corporation Reports Fourth Quarter and Fiscal Year 2021 ResultsBusiness Wire | March 9th
- ChromaDex to Report Fourth Quarter 2021 Financial Results on Wednesday, March 9, 2022Business Wire | February 22nd
- ChromaDex and Designs for Health Partner for New Product Development on Niagen®Business Wire | January 20th
Company Info
Website: https://www.chromadex.com
Address: 10900 Wilshire Boulevard, Los Angeles, CA, United States, 90024
Sector: Healthcare
Industry: Biotechnology
Full time employees: 115
Address: 10900 Wilshire Boulevard, Los Angeles, CA, United States, 90024
Sector: Healthcare
Industry: Biotechnology
Full time employees: 115
$CDXC keep it going
$CDXC I do it for the thrills!
$CDXC just hold no panic
$CDXC COME ON!!! Ugh!
$CDXC might get a sell off today
$CDXC Keep up the pressure.
$CDXC buy more doomers!!!
$CDXC very normal lol sike
$CDXC what V recovery or fake pump
$CDXC Hedgies
we aren't going anywhere!